
Strides Pharma Science Limited has informed the Exchange regarding a press release dated May 27, 2021, titled "TLC and Strides partner to launch Liposomal Amphotericin B in India".
Filed with NSE ·

Strides Pharma Science Limited has informed the Exchange regarding a press release dated May 27, 2021, titled "TLC and Strides partner to launch Liposomal Amphotericin B in India".
6ix hasn’t read this filing yet.
Strides Pharma Science Ltd on 6ix
Follow Strides Pharma Science into a list and get an email when it puts out news.
Follow Strides Pharma Science